Arbutus Biopharma Corp
Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing
3.1
0.1
(3.333%)
Volume:
479,296
52 week range:
1.85 - 3.22
Market Cap:
503.97M
Company Description:
Arbutus Biopharma Corporation is a biopharmaceutical company primarily dedicated to discovering, developing and commercializing a cure for people with chronic hepatitis B virus (HBV) infection. The Company is advancing multiple drug product candidates that may be combined into a potentially curative regimen for chronic HBV infection. Arbutus has also initiated a drug discovery and development effort for treating coronaviruses (including COVID-19).